Research location
Bari
Italy
Advertisement
Research activity in Bari
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 311 trials and 323 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Bari
311 linked trials · page 3 of 7Establishment of the Human Intestinal and Salivary Microbiota Biobank - ObesityNCT04698135 · 2021-03-25 · 1 site observation
COMPLETED
Incidence and Echocardiographic Predictors of HFpEF in High-Risk Population Afferent to Italian Echo-labs NetworkNCT05753553 · 2021-03-02 · 1 site observation
UNKNOWN
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Oncologic DiseasesNCT04698161 · 2021-02-25 · 1 site observation
COMPLETED
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C MutationNCT04685135 · 2021-02-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney DiseasesNCT04689074 · 2021-02-03 · 1 site observation
COMPLETED
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic PhenotypeNCT04718389 · 2021-01-26 · 1 site observation
COMPLETED
A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell FunctionNCT04628481 · 2021-01-12 · 1 site observation
TERMINATED
Effects of Bromelain and Boswellia Serrata Casperome With Centella Asiatica and Vitamins on Edema, Paresthesia and Postoperative Pain After Quadrantectomy With or Without Sentinel Lymph Node Biopsy.NCT04669119 · 2020-12-31 · 1 site observation
UNKNOWN
A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung CancerNCT04351555 · 2020-12-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)NCT04609878 · 2020-12-15 · 1 site observation
COMPLETED
A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.NCT04899271 · 2020-12-14 · 1 site observation
TERMINATED
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)NCT04622319 · 2020-12-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Comparing Transanal Irrigation With Navina Smart vs. Standard Bowel Care in Patients With Multiple SclerosisNCT04707976 · 2020-12-01 · 1 site observation
UNKNOWN
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung CancerNCT04475939 · 2020-10-26 · 1 site observation
COMPLETED
A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid ArthritisNCT04497597 · 2020-10-16 · 1 site observation
COMPLETED
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and ImmunotherapyNCT04591431 · 2020-10-07 · 1 site observation
UNKNOWN
A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or SelexipagNCT04567602 · 2020-10-06 · 2 site observations
COMPLETED
Effects of COVID-19 Pandemic on the Outcomes of Colorectal CancerNCT04712292 · 2020-09-08 · 2 site observations
UNKNOWN
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of SchizophreniaNCT04531982 · 2020-08-05 · 1 site observation
COMPLETED
Study of Evobrutinib in Participants With RMS (evolutionRMS 2)NCT04338061 · 2020-07-02 · 1 site observation
TERMINATED
COVID-19 Infection and Multiple MyelomaNCT04492371 · 2020-07-01 · 1 site observation
COMPLETED
Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).NCT04303780 · 2020-06-04 · 1 site observation
COMPLETED
COVID19-hematological Malignancies: the Italian Hematology AllianceNCT04352556 · 2020-04-07 · 2 site observations
UNKNOWN
Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT)NCT03896074 · 2020-03-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)NCT04191096 · 2020-02-12 · 1 site observation
TERMINATED
Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)NCT04227327 · 2020-01-07 · 1 site observation
TERMINATED
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil LevelNCT04133909 · 2019-10-30 · 1 site observation
COMPLETED
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical PracticeNCT04094415 · 2019-10-28 · 1 site observation
COMPLETED
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer PatientsNCT05730647 · 2019-10-24 · 2 site observations
ACTIVE_NOT_RECRUITING
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)NCT03961204 · 2019-08-15 · 1 site observation
COMPLETED
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)NCT03904693 · 2019-07-29 · 1 site observation
COMPLETED
Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerNCT03906071 · 2019-07-15 · 1 site observation
TERMINATED
A Real-world Study of Imraldi® UseNCT04089514 · 2019-06-30 · 1 site observation
COMPLETED
Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008)NCT03976375 · 2019-06-26 · 1 site observation
COMPLETED
Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple SclerosisNCT03926637 · 2019-06-17 · 1 site observation
TERMINATED
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)NCT03867084 · 2019-05-28 · 1 site observation
COMPLETED
Crizotinib in ALK Rearranged Non-small-cell Lung CancerNCT04317651 · 2019-05-16 · 1 site observation
UNKNOWN
Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)NCT03898180 · 2019-05-06 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 DiabetesNCT03882970 · 2019-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)NCT03711032 · 2018-12-24 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung CancerNCT03800134 · 2018-12-06 · 1 site observation
ACTIVE_NOT_RECRUITING
ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung CancerNCT03445000 · 2018-11-06 · 1 site observation
TERMINATED
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)NCT03553836 · 2018-09-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of Excellence in Italy's Residence for Execution of Security MeasureNCT06018298 · 2018-07-01 · 1 site observation
COMPLETED
Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)NCT03515837 · 2018-06-29 · 1 site observation
COMPLETED
A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory MelanomaNCT03445533 · 2018-05-30 · 2 site observations
TERMINATED
A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene MutationNCT03439514 · 2018-04-17 · 2 site observations
TERMINATED
Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGationNCT03100253 · 2018-03-01 · 1 site observation
TERMINATED
A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of SchizophreniaNCT03382639 · 2018-01-04 · 1 site observation
COMPLETED
Pembrolizumab (MK-3475) as Maintainance in Treated Patients With Unresectable Stage III NSCLCNCT03379441 · 2018-01-01 · 1 site observation
UNKNOWN
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.